Millennium Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Millennium Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-7,600	Closed	-$266K	–	4534
2014 Q3	$266K	Buy	+7,600	New	+$261K	﹤0.01%	3185

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Millennium Management's WX Position: Q4 2015 in Review

Millennium Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 16,100 shares — an estimated $696K sold.

Millennium Management first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $33.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Millennium Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Millennium Management sold 16,100 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $696K.
Millennium Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
Millennium Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $33.4M in Q1 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.